Treatment for Migraine and Mood (TEAM-M): A Pilot Trial of Mindfulness-based Training Program

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Depressive Symptoms
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Currently meets ICHD-3 criteria for migraine using the Structured Diagnostic Interview for Headache
    2. Self-reported 4-14 headache days per month, with at least one attack meeting migraine criteria
    3. Score between 5-14 on the PHQ-9
    4. Ability to read and speak English
    5. Able to provide written informed consent form

You may not be eligible for this study if the following are true:

    1. Meeting ICHD-3 criteria for persistent headache attributed to traumatic injury to the head (post-traumatic headache) on the Structure Diagnostic Interview for Headache
    2. Changes in preventive migraine medication or anti-depressant medication within 6 weeks of intake; changes in longer-term migraine prevention (onobotulinum toxin A, anti-calcitonin gene related peptide treatment) within 3 months of intake
    3. Comorbid psychiatric illness or clinical features that would interfere with participant’s ability to participate in or receive benefit from the MBCT-T intervention, including but not limited to: active suicidal ideation; recent history of psychosis or mania; borderline, histrionic or narcissistic personality disorder; cognitive impairment; sensory disabilities; bipolar disorder; obsessive-compulsive disorder
    4. Prior history of engaging in formal mindfulness-based interventions including: MBSR, MBCT, Acceptance and Commitment therapy, Dialectical Behavior Therapy
    5. Current meditation practice >3x/week

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.